Life Science Instrumentation Market Size, Share, and Trends 2025 to 2034

The global life science instrumentation market size is predicted to increase from USD 67.19 billion in 2024, grew to USD 70.69 billion in 2025 and is anticipated to reach around USD 111.55 billion by 2034, poised to grow at a CAGR of 5.20% between 2024 and 2034. The North America life science instrumentation market size is calculated at USD 20.16 billion in 2024 and is estimated to grow at a fastest CAGR of 5.37% during the forecast year.

Last Updated : July 2025  |  Report Code : 1471  |  Category : Healthcare  |  Format : PDF / PPT / Excel

Life Science Instrumentation Market

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Life Science Instrumentation Market 

5.1. COVID-19 Landscape: Life Science Instrumentation Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Life Science Instrumentation Market, By Spectroscopy

8.1. Life Science Instrumentation Market, by Spectroscopy

8.1.1 Spectroscopy

8.1.1.1. Market Revenue and Forecast

8.1.2. Chromatography

8.1.2.1. Market Revenue and Forecast

8.1.3. Polymerase Chain Reaction (PCR)

8.1.3.1. Market Revenue and Forecast

8.1.4. Polymerase Chain Reaction (PCR)

8.1.4.1. Market Revenue and Forecast

8.1.5. Flow Cytometry

8.1.5.1. Market Revenue and Forecast

8.1.6. Microscopy

8.1.6.1. Market Revenue and Forecast

8.1.7. Electrophoresis

8.1.7.1. Market Revenue and Forecast

8.1.8. Centrifuges

8.1.8.1. Market Revenue and Forecast

8.1.9. Lab Automation & Liquid Handling

8.1.9.1. Market Revenue and Forecast

8.1.10. Cell Counting Instruments

8.1.10.1. Market Revenue and Forecast

8.1.11. Other

8.1.11.1. Market Revenue and Forecast

Chapter 9. Global Life Science Instrumentation Market, By Application

9.1. Life Science Instrumentation Market, by Application

9.1.1. Clinical and Diagnostic Applications

9.1.1.1. Market Revenue and Forecast

9.1.2. Research Applications

9.1.2.1. Market Revenue and Forecast  

Chapter 10. Global Life Science Instrumentation Market, By End-User

10.1. Life Science Instrumentation Market, by End-User

10.1.1. Research Applications

10.1.1.1. Market Revenue and Forecast

10.1.2. Clinical Diagnostic Laboratories

10.1.2.1. Market Revenue and Forecast

10.1.3. Academic & Research Institutions

10.1.3.1. Market Revenue and Forecast

10.1.4. Hospitals & Healthcare Facilities

10.1.4.1. Market Revenue and Forecast

10.1.5. Contract Research Organizations (CROs)

10.1.5.1. Market Revenue and Forecast

10.1.6. Food & Beverage Industry

10.1.6.1. Market Revenue and Forecast

10.1.7. Food & Beverage Industry

10.1.7.1. Market Revenue and Forecast

10.1.8. Food & Beverage Industry

10.1.8.1. Market Revenue and Forecast

Chapter 11. Global Life Science Instrumentation Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Spectroscopy  

11.1.2. Market Revenue and Forecast, by Application

11.1.3. Market Revenue and Forecast, by End-User

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Spectroscopy  

11.1.4.2. Market Revenue and Forecast, by Application

11.1.4.3. Market Revenue and Forecast, by End-User

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Spectroscopy  

11.1.5.2. Market Revenue and Forecast, by Application

11.1.5.3. Market Revenue and Forecast, by End-User

11.2. Europe

11.2.1. Market Revenue and Forecast, by Spectroscopy  

11.2.2. Market Revenue and Forecast, by Application

11.2.3. Market Revenue and Forecast, by End-User

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Spectroscopy  

11.2.4.2. Market Revenue and Forecast, by Application

11.2.4.3. Market Revenue and Forecast, by End-User

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Spectroscopy  

11.2.5.2. Market Revenue and Forecast, by Application

11.2.5.3. Market Revenue and Forecast, by End-User

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Spectroscopy  

11.2.6.2. Market Revenue and Forecast, by Application

11.2.6.3. Market Revenue and Forecast, by End-User

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Spectroscopy  

11.2.7.2. Market Revenue and Forecast, by Application

11.2.7.3. Market Revenue and Forecast, by End-User

11.3. APAC

11.3.1. Market Revenue and Forecast, by Spectroscopy  

11.3.2. Market Revenue and Forecast, by Application

11.3.3. Market Revenue and Forecast, by End-User

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Spectroscopy  

11.3.4.2. Market Revenue and Forecast, by Application

11.3.4.3. Market Revenue and Forecast, by End-User

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Spectroscopy  

11.3.5.2. Market Revenue and Forecast, by Application

11.3.5.3. Market Revenue and Forecast, by End-User

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Spectroscopy  

11.3.6.2. Market Revenue and Forecast, by Application

11.3.6.3. Market Revenue and Forecast, by End-User

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Spectroscopy  

11.3.7.2. Market Revenue and Forecast, by Application

11.3.7.3. Market Revenue and Forecast, by End-User

11.4. MEA

11.4.1. Market Revenue and Forecast, by Spectroscopy  

11.4.2. Market Revenue and Forecast, by Application

11.4.3. Market Revenue and Forecast, by End-User

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Spectroscopy  

11.4.4.2. Market Revenue and Forecast, by Application

11.4.4.3. Market Revenue and Forecast, by End-User

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Spectroscopy  

11.4.5.2. Market Revenue and Forecast, by Application

11.4.5.3. Market Revenue and Forecast, by End-User

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Spectroscopy  

11.4.6.2. Market Revenue and Forecast, by Application

11.4.6.3. Market Revenue and Forecast, by End-User

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Spectroscopy  

11.4.7.2. Market Revenue and Forecast, by Application

11.4.7.3. Market Revenue and Forecast, by End-User

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Spectroscopy  

11.5.2. Market Revenue and Forecast, by Application

11.5.3. Market Revenue and Forecast, by End-User

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Spectroscopy  

11.5.4.2. Market Revenue and Forecast, by Application

11.5.4.3. Market Revenue and Forecast, by End-User

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Spectroscopy  

11.5.5.2. Market Revenue and Forecast, by Application

11.5.5.3. Market Revenue and Forecast, by End-User

Chapter 12. Company Profiles

12.1 Bruker Corporation

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Eppendorf AG

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Hitachi High Technologies Corporation

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Becton Dickinson and Company

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Bio-Rad Laboratories Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Waters Corporation

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Thermo Fisher Scientific

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Agilent Technologies

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Shimadzu Corporation

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Qiagen N.V.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global life science instrumentation market size was worth at USD 67.19 billion in 2024 and is predicted to reach over US$ 111.55 billion by 2034.

The global life science instrumentation market is expected to drive growth at a CAGR of 5.20% from 2024 to 2034.

The increased spending on research and development by pharmaceutical and biotechnology businesses, increased public and private financing for life science research, and rising incidence of target diseases and genetic disorders are all driving the life science instrumentation market expansion.

The major players operating in the life science instrumentation market are Bruker Corporation, Eppendorf AG, Hitachi High Technologies Corporation, Becton Dickinson and Company, Bio-Rad Laboratories Inc., Waters Corporation, Thermo Fisher Scientific, Agilent Technologies, Shimadzu Corporation, Qiagen N.V..

North America is the largest segment for life science instrumentation market in terms of region. The increased need for drug discovery, rising frequency of chronic diseases, and increased demand for rising food safety concerns are among the drivers driving the growth of the North American life science instrumentation market.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client